Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | BIIB | BNTX | ||
| Company | Royalty Pharma Plc Cl A | Biogen Inc | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.81 | 179.46 | 86.29 | ||
| High | 47.97 | 184.59 | 89.54 | ||
| Low | 46.68 | 172.65 | 86.29 | ||
| Latest | 47.97 | 183.35 | 88.85 | ||
| Change | +1.60 | -4.22 | +3.60 | ||
| % Change | +3.44% | -2.25% | +4.22% | ||
| Volume | 3,376,284 | 2,713,009 | 854,418 | ||
| 20-Day Average Volume | 3,411,294 | 1,007,980 | 1,822,181 | ||
| Previous Close | 46.37 | 187.57 | 85.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.16 | 185.74 | 91.53 | ||
| 20-Day Raw Stochastic | 99.69% | 52.61% | 37.97% | ||
| 20-Day Relative Strength | 65.87 | 48.29 | 41.35 | ||
| Weighted Alpha | +57.12 | +47.43 | -8.91 | ||
| Today's Opinion | 100% Buy | 64% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 96% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.26% since 03/24/26 | -0.32% since 03/24/26 | +2.34% since 03/24/26 | ||
| Low | 45.79 on 03/25/26 | 172.65 on 03/31/26 | 84.78 on 03/30/26 | ||
| High | 47.97 on 03/31/26 | 192.27 on 03/26/26 | 89.54 on 03/31/26 | ||
| 1-Month | |||||
| %Chg | +3.80% since 02/27/26 | -4.42% since 02/27/26 | -19.40% since 02/27/26 | ||
| Low | 44.73 on 03/20/26 | 172.65 on 03/31/26 | 79.52 on 03/10/26 | ||
| High | 47.97 on 03/31/26 | 192.99 on 03/11/26 | 110.10 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +22.30% since 12/26/25 | +3.54% since 12/26/25 | -6.00% since 12/26/25 | ||
| Low | 38.29 on 01/02/26 | 160.36 on 01/20/26 | 79.52 on 03/10/26 | ||
| High | 47.97 on 03/31/26 | 202.41 on 02/06/26 | 124.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +36.89% since 09/26/25 | +33.47% since 09/26/25 | -9.42% since 09/26/25 | ||
| Low | 34.79 on 09/29/25 | 135.39 on 09/29/25 | 79.52 on 03/10/26 | ||
| High | 47.97 on 03/31/26 | 202.41 on 02/06/26 | 124.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,748,858 | 27,527,588 | 21,425,456 | ||
| Shares Outstanding, K | 576,857 | 146,759 | 251,325 | ||
| Annual Sales | 2,378,190,000 | 9,890,600,000 | 3,247,010,000 | ||
| Annual Net Income | 770,950,000 | 1,292,900,000 | -1,285,380,000 | ||
| Last Quarter Sales | 621,990,000 | 2,279,400,000 | 982,920,000 | ||
| Last Quarter Net Income | 214,210,000 | -48,900,000 | -374,920,000 | ||
| 60-Month Beta | 0.40 | 0.15 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.46 on 02/11/26 | 1.99 on 02/06/26 | -0.38 on 03/10/26 | ||
| Latest Earnings Date | 05/14/26 | 05/07/26 | 05/04/26 | ||
| Most Recent Dividend | 0.235 on 02/20/26 | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | 02/20/26 | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 9.60 | 12.02 | 0.00 | ||